Cover Image

O1 Hepatitis C: the treatment landscape in 2017

Saved in:

Bibliographic Details
Main Author:	Gregory J. Dore (Author)
Format:	Book
Published:	Elsevier, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy
by: Richard Hallinan, et al.
Published: (2004)

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017)

Review of antenatal testing policies and practice for HIV and hepatitis C infection
by: Jenean D. Spencer, et al.
Published: (2003)

Scientific Landscape of Dental Literature in 2017
by: Jafar Kolahi, et al.
Published: (2018)

Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study
by: Amin Janaki, et al.
Published: (2011)

O16 A regional prison cleared of hepatitis C in less than 12 months
by: D.B. Russell, et al.
Published: (2017)

O4 Outcomes of treatment for hepatitis C virus infection in the prison setting
by: T. Papaluca, et al.
Published: (2017)

Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021
by: Xinyu Du, et al.
Published: (2023)

Hepatitis C Treatment Outcomes in Kigali, Rwanda
by: S. Taylor, et al.
Published: (2016)

O11 Hepatitis C: stigma indicators and patient reported outcome measures for DAA treatment
by: C. Treloar, et al.
Published: (2017)

Advances in Treatment of Hepatitis C and B
Published: (2017)

Treatment guidelines for Hepatitis C in Spain
by: M. Crespo-Casal

Chronic hepatitis C: future treatment
by: Wendt A, et al.
Published: (2014)

Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep studyResearch in context
by: Rugiatu Bah, et al.
Published: (2024)

O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study
by: B. Hajarizadeh, et al.
Published: (2017)

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
by: Kanda T, et al.
Published: (2014)

Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort
by: Dolan Kate, et al.
Published: (2010)

O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study
by: M. Alavi, et al.
Published: (2017)

Perspectivas futuras en el tratamiento de la hepatitis crónica C Future perspective in the treatment of chronic hepatitis C
by: J.V. Fernández-Montero, et al.
Published: (2011)

Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation
by: Bridget Draper, et al.
Published: (2024)

New perspectives in the pharmacological treatment of Hepatitis C
by: Sol Gomez Aparicio, et al.
Published: (2016)

Prospects for current hepatitis C treatment failures
by: Vicente Soriano
Published: (2016)

Simeprevir for the treatment of hepatitis C virus infection
by: Izquierdo L, et al.
Published: (2014)

O27 Eliminating hepatitis C in the prisons: achievable?
by: Andrew Lloyd
Published: (2017)

O30 Eliminating hepatitis C: the Cairns experience
by: D.B. Russell
Published: (2017)

O17 Eliminate Hepatitis C Partnership: clinical site scoping
by: E. Wong, et al.
Published: (2017)

Ideology and Holy Landscape in the Baltic Crusades
by: Leighton, Gregory
Published: (2022)

Ideology and Holy Landscape in the Baltic Crusades
by: Leighton, Gregory
Published: (2022)

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
by: El Khoury AC, et al.
Published: (2012)

Nuevos avances en el manejo de la hepatitis C Current advances in hepatitis C treatment
by: Laura E. Cisneros-Garza
Published: (2011)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010)

Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014)

C the Light! Exploring Dynamic Changes in Hepatitis C Epidemiology, Screening, and Treatment
by: Lesley Miller, et al.
Published: (2017)

Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine
by: Eduardo Guimarães Pereira, et al.
Published: (2016)

Profile of alisporivir and its potential in the treatment of hepatitis C
by: Gallay PA, et al.
Published: (2013)

P1 Hepatitis C CALD community outreach
by: D. Abdelsalam
Published: (2017)

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C
by: Kuroda Masahiko, et al.
Published: (2010)

O14 Community prescribing of hepatitis C treatment: a mentorship and capacity building model to increase treatment uptake by targeted populations
by: S. Watkinson, et al.
Published: (2017)

Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney
by: Bethany White, et al.
Published: (2012)